Year: 2023
Type: article
Abstract: This study was designed to investigate the controversy on the potential role of sKlotho as an early biomarker in Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD), to assess whether sKlotho is a reliable marker of kidney α-Klotho, to deepen the effects of sKlotho on vascular smooth muscle cells (VSMCs) osteogenic differentiation and to evaluate the role of autophagy in this process. Experimental studies were conducted in CKD mice fed a normal phosphorus (CKD+NP) or high phosphorus (CKD+HP) diet for 14 weeks. The patients' study was performed in CKD stages 2-5 and in vitro studies which used VSMCs exposed to non-calcifying medium or calcifying medium with or without sKlotho. The CKD experimental model showed that the CKD+HP group reached the highest serum PTH, P and FGF23 levels, but the lowest serum and urinary sKlotho levels. In addition, a positive correlation between serum sKlotho and kidney α-Klotho was found. CKD mice showed aortic osteogenic differentiation, together with increased autophagy. The human CKD study showed that the decline in serum sKlotho is previous to the rise in FGF23. In addition, both serum sKlotho and FGF23 levels correlated with kidney function. Finally, in VSMCs, the addition of sKlotho prevented osteogenic differentiation and induced autophagy. It can be concluded that serum sKlotho was the earliest CKD-MBD biomarker, a reliable indicator of kidney α-Klotho and that might protect against osteogenic differentiation by increasing autophagy. Nevertheless, further studies are needed to investigate the mechanisms of this possible protective effect.
Source: Nutrients
DOI: 10.3390/nu15061470
Authors: Julia Martín-Vírgala, Sara Fernández-Villabrille, Beatriz Martín-Carro, Isaac Tamargo-Gómez, Juan F. Navarro-González, Carmen Mora-Fernández, Laura Calleros, Elena Astudillo-Cortés, Noelia Avello-Llano, Guillermo Mariño, Adriana S. Dusso, Cristina Alonso-Montes, Sara Panizo, Jorge B. Cannata-Andía, Manuel Naves-Díaz, Natalia Carrillo-López
Institutions: Universidad de Oviedo, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Universidad de La Laguna, Hospital Universitario Nuestra Señora de Candelaria, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria, Fundación Renal Española, Washington University in St. Louis
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,892
Awards: G1013874393, G1075404386, G1158155489, G1318231304, G1647210306, G2112522018, G223923816, G2303849486, G2352733501, G2854544501, G3076129328, G3301950926, G3721511862, G4022723184, G425816975, G4327487443, G444356502, G507617479, G5169331880, G5488964111, G5521673437, G5559904687, ALTERACIONES ESQUELÉTICAS Y CARDIOVASCULARES ASOCIADAS AL ENVEJECIMIENTO: PAPEL Y REGULACIÓN DE LGR4, EL NUEVO RECEPTOR DEL SISTEMA RANK / RANKL / OPG, FRACTURAS DE FRAGILIDAD ÓSEA EN DIABÉTICOS CON ENFERMEDAD RENAL CRÓNICA: MECANISMOS INVOLUCRADOS, PAPEL DE LAS ALTERACIONES DE PTH-FÓSFORO-CALCIO, G6005473923, Efecto de PTH y Klotho sobre alteraciones óseas, vasculares y renales en la insuficiencia renal crónica experimental: Papel de la vía de Wnt., Klotho soluble en la enfermedad renal crónica (ERC): Importancia en el envejecimiento esquelético, vascular e inmunológico., G7867239748, G8203297139, G976395392
OpenAlex ID: W4327975688
